What is MGP Ingredients's granted (in shares)?

MGP Ingredients (MGPI) reported granted (in shares) of $28.54 in Q4 2025.

What does granted (in shares) mean?

The weighted average exercise price of stock options granted to employees and directors during the reporting period. This metric reflects the company's cost of equity-based incentives and the strike price set for new option awards.

MGP Ingredients MGPI Granted (in shares)

Granted (in shares) at other companies

IngredionINGR

$0.00-100%

Boston BeerSAM

$0.00-100%

Other financials

Income statement

See full

Revenue$106.4M-12.5%

Gross profit$33.6M-22.5%

Operating income-$173.2M-23,086%

Net income-$134.8M-4,358%

EPS (diluted)-$6.30-4,400%

Balance sheet

See full

Cash & equivalents$10.4M-48.5%

Total debt$260.4M-17.7%

Total equity$581.3M-29.8%

Total assets$1.0B-25.2%

Cash flow

See full

Operating cash flow$7.0M-84.4%

CapEx$5.7M-71.3%

Free cash flow$1.2M-95.0%

Valuation

See full

Market cap$349.42M-44.4%

Enterprise value$599.43M-35.1%

P/S0.7×-0.3×

Profitability

See full

Gross margin36.4%-4.4pp

Operating margin-51.2%—

Net margin-46%—

FCF margin10.2%+1.3pp

Returns & leverage

See full

Return on equity-34%—

Debt / equity0.4×+0.1×

Current ratio2.7×-0.1×

Where this comes from

Reported directly by MGP Ingredients in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice.

The official record: MGP Ingredients’s 10-K, filed February 25, 2026, on SEC EDGAR. View the filing →

Ask your AI about MGP Ingredients's granted (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is MGP Ingredients's granted (in shares)?: MGP Ingredients (MGPI) reported granted (in shares) of $28.54 in Q4 2025.
What does granted (in shares) mean?: The weighted average exercise price of stock options granted to employees and directors during the reporting period. This metric reflects the company's cost of equity-based incentives and the strike price set for new option awards.